Global Observational Registry for Patients Treated with Inari Medical Devices for Pulmonary Embolism

What this Trial Is About

Researchers are collecting data in a global, prospective, non-randomized, multicenter registry to observe the use of commercially approved Inari Medical devices in patients with pulmonary embolism. This study aims to gather active post-market information on these devices to understand their real-world use and monitor safety over time. Participants in this observational registry have received treatment with eligible Inari Medical devices. There is no randomization or placebo group. Data collection focuses on routine clinical use of these devices without altering standard care. During the study, participants will be followed for up to 180 days to monitor the incidence of device-related, procedure-related, or fatal adverse events. Researchers will collect safety data through scheduled follow-ups and record relevant clinical information. The total duration of participation depends on the timing of enrollment relative to device treatment and follow-up availability.

Inari VISION Registry